Interleukin-27 suppresses osteoclastogenesis via induction of interferon-γ

Immunology

Volumn 137, Issue 4, 2012, Pages 326-335

  Park, Jin Sil ^a   Jung, Young Ok ^b   Oh, Hye Joa ^a   Park, Seong Jeong ^c   Heo, Yu Jung ^a   Kang, Chang Min ^a   Kwok, Seung Ki ^a   Ju, Ji Hyeon ^a   Park, Kyung Su ^a   Cho, Mi La ^a   Sung, Young Chul ^c   Park, Sung Hwan ^a   Kim, Ho Youn ^a  

^a The Catholic University of Korea   (South Korea)

^b Hallym University   (South Korea)

^c Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Collagen induced arthritis; Interferon ; Interleukin 27; Interleukin 27 Fc; Osteoclastogenesis

Indexed keywords

FC RECEPTOR; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; INTERLEUKIN 27; PHOSPHATASE; TARTARIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EXPERIMENTAL MODEL; IN VITRO STUDY; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CELL DIFFERENTIATION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; OSTEOCLASTS; OSTEOGENESIS;

EID: 84869838745     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2012.03622.x     Document Type: Article

References (37)

1. + T cells. Immunity 2002; 16:779-90.
2. Yoshida H, Miyazaki Y. Regulation of immune responses by interleukin-27. Immunol Rev 2008; 226:234-47.
3. Goldberg R, Wildbaum G, Zohar Y, Maor G, Karin N. Suppression of ongoing adjuvant-induced arthritis by neutralizing the function of the p28 subunit of IL-27. J Immunol 2004; 173:1171-8.
4. Goldberg R, Zohar Y, Wildbaum G, Geron Y, Maor G, Karin N. Suppression of ongoing experimental autoimmune encephalomyelitis by neutralizing the function of the p28 subunit of IL-27. J Immunol 2004; 173:6465-71.
5. Cao Y, Doodes PD, Glant TT, Finnegan A. IL-27 induces a Th1 immune response and susceptibility to experimental arthritis. J Immunol 2008; 180:922-30.
6. Batten M, Li J, Yi S et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 2006; 7:929-36.
7. Niedbala W, Cai B, Wei X, Patakas A, Leung BP, McInnes IB, Liew FY. Interleukin 27 attenuates collagen-induced arthritis. Ann Rheum Dis 2008; 67:1474-9.
8. Furukawa M, Takaishi H, Takito J et al. IL-27 abrogates receptor activator of NF-κB ligand-mediated osteoclastogenesis of human granulocyte-macrophage colony-forming unit cells through STAT1-dependent inhibition of c-Fos. J Immunol 2009; 183:2397-406.
9. Kalliolias GD, Zhao B, Triantafyllopoulou A, Park-Min KH, Ivashkiv LB. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling. Arthritis Rheum 2010; 62:402-13.
10. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003; 423:356-61.
11. Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 2000; 43:250-8.
12. Bromley M, Woolley DE. Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint. Arthritis Rheum 1984; 27:968-75.
13. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003; 423:337-42.
14. Pettit AR, Walsh NC, Manning C, Goldring SR, Gravallese EM. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis. Rheumatology (Oxford) 2006; 45:1068-76.
15. Matthys P, Vermeire K, Mitera T et al. Enhanced autoimmune arthritis in IFN-γ receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells. J Immunol 1999; 163:3503-10.
16. Kohara H, Kitaura H, Fujimura Y et al. IFN-γ directly inhibits TNF-α-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions. Immunol Lett 2011; 137:53-61.
17. + myelopoiesis. Arthritis Res Ther 2004; 6:R220-31.
18. Takayanagi H, Ogasawara K, Hida S et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 2000; 408:600-5.
19. Takeda A, Hamano S, Yamanaka A et al. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol 2003; 170:4886-90.
20. Inglis JJ, Simelyte E, McCann FE, Criado G, Williams RO. Protocol for the induction of arthritis in C57BL/6 mice. Nat Protoc 2008; 3:612-8.
21. Rosloniec EF, Cremer M, Kang A, Myers LK. Collagen-induced arthritis. Curr Protoc Immunol 2001; Chapter 15:Unit 15 5.
22. Zheng XX, Steele AW, Nickerson PW, Steurer W, Steiger J, Strom TB. Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation. J Immunol 1995; 154:5590-600.
23. Ha SJ, Jeon BY, Kim SC, Kim DJ, Song MK, Sung YC, Cho SN. Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis. Gene Ther 2003; 10:1592-9.
24. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
25. Camps M, Ruckle T, Ji H et al. Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 2005; 11:936-43.
26. Johnson EB, Hammer RE, Herz J. Abnormal development of the apical ectodermal ridge and polysyndactyly in Megf7-deficient mice. Hum Mol Genet 2005; 14:3523-38.
27. Zhang M, Yan Y, Lim YB et al. BMP-2 modulates beta-catenin signaling through stimulation of Lrp5 expression and inhibition of β-TrCP expression in osteoblasts. J Cell Biochem 2009; 108:896-905.
28. Smits P, Li P, Mandel J et al. The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell 2001; 1:277-90.
29. Takahashi N, Mundy GR, Roodman GD. Recombinant human interferon-γ inhibits formation of human osteoclast-like cells. J Immunol 1986; 137:3544-9.
30. Fox SW, Chambers TJ. Interferon-γ directly inhibits TRANCE-induced osteoclastogenesis. Biochem Biophys Res Commun 2000; 276:868-72.
31. Stumhofer JS, Hunter CA. Advances in understanding the anti-inflammatory properties of IL-27. Immunol Lett 2008; 117:123-30.
32. Pickens SR, Chamberlain ND, Volin MV et al. Local expression of interleukin-27 ameliorates collagen-induced arthritis. Arthritis Rheum 2011; 63:2289-98.
33. Wong CK, Chen da P, Tam LS, Li EK, Yin YB, Lam CW. Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 2010; 12:R129.
34. Stumhofer JS, Laurence A, Wilson EH et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 2006; 7:937-45.
35. Schoenborn JR, Wilson CB. Regulation of interferon-γ during innate and adaptive immune responses. Adv Immunol 2007; 96:41-101.
36. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-γ: an overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75:163-89.
37. Ji JD, Park-Min KH, Shen Z, Fajardo RJ, Goldring SR, McHugh KP, Ivashkiv LB. Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-γ in human osteoclast precursors. J Immunol 2009; 183:7223-33.